Sunday, June 14, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 294 of 1,261

  1. US 11198693

    Functionalized heterocycles as antiviral agents

    Enanta Pharmaceuticals, Inc. · Granted Dec 14, 2021 · Expires Dec 9, 2041

    granted

  2. US 11197916

    Lyophilized recombinant VWF formulations

    Takeda Pharmaceutical Company Limited · Granted Dec 14, 2021 · Expires Dec 9, 2041

    granted

  3. US 11197869

    Istaroxime-containing intravenous formulation for the treatment of acute heart failure (AHF)

    Windtree Therapeutics, Inc. · Granted Dec 14, 2021 · Expires Dec 9, 2041

    granted

  4. US 11197847

    Isoxazoline parasiticide formulations and methods for treating blepharitis

    Tarsus Pharmaceuticals, Inc. · Granted Dec 14, 2021 · Expires Dec 9, 2041

    granted

  5. US 11197821

    Formulations for treatment of dry eye disease

    Aldeyra Therapeutics, Inc. · Granted Dec 14, 2021 · Expires Dec 9, 2041

    granted

  6. US 11198689

    Compositions and methods for inhibition of the JAK pathway

    Rigel Pharmaceuticals, Inc. · Granted Dec 14, 2021 · Expires Dec 9, 2041

    granted

  7. US 11198724

    Treatment of staphylococcal disorders

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Dec 14, 2021 · Expires Dec 9, 2041

    granted

  8. US 11197884

    Modulation of the notch signaling pathway for treatment of respiratory disorders

    Ionis Pharmaceuticals, Inc. · Granted Dec 14, 2021 · Expires Dec 9, 2041

    granted

  9. US 11197883

    Inhibition of stress granule formation through manipulation of UBAP2L

    The Regents of the University of California · Granted Dec 14, 2021 · Expires Dec 9, 2041

    granted

  10. US 11197870

    Treatment for hepatic fibrosis

    GALMED RESEARCH AND DEVELOPMENT LTD · Granted Dec 14, 2021 · Expires Dec 9, 2041

    granted

  11. US 11197879

    Flavonoid compositions and uses thereof

    The United States of America, as represented by the Secretary of Agriculture · Granted Dec 14, 2021 · Expires Dec 9, 2041

    granted

  12. US 11197876

    Effects of LGM2605 on a primate model of asthma

    The Regents of the University of California · Granted Dec 14, 2021 · Expires Dec 9, 2041

    granted

  13. US 11198872

    Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof

    Alnylam Pharmaceuticals, Inc. · Granted Dec 14, 2021 · Expires Dec 9, 2041

    granted

  14. US 11197833

    Fortified CBD oil for treatment of PTSD

    Bright Green Corporation · Granted Dec 14, 2021 · Expires Dec 9, 2041

    granted

  15. US 11197844

    Triple drug combination (metformin, simvastatin, digoxin) for targeted treatment of pancreatic cancer

    The Regents of the University of California · Granted Dec 14, 2021 · Expires Dec 9, 2041

    granted

  16. US 11197837

    Methods and compositions for interfering with extraction or conversion of a drug susceptible to abuse

    Acurx Pharmaceuticals, Inc. · Granted Dec 14, 2021 · Expires Dec 9, 2041

    granted

  17. US 11198858

    Codon optimized GLA genes and uses thereof

    4D MOLECULAR THERAPEUTICS INC. · Granted Dec 14, 2021 · Expires Dec 9, 2041

    granted

  18. US 11198691

    N-((het)arylmethyl)-heteroaryl-carboxamides compounds as kallikrein inhibitors

    KalVista Pharmaceuticals Limited · Granted Dec 14, 2021 · Expires Dec 9, 2041

    granted

  19. US 11198699

    Compounds targeting PRMT5

    Aligos Therapeutics, Inc. · Granted Dec 14, 2021 · Expires Dec 9, 2041

    granted

  20. US 11198682

    Substituted pyrimidines as inhibitors for a Rho family of GTP-ases

    The Regents of the University of California · Granted Dec 14, 2021 · Expires Dec 9, 2041

    granted

  21. US 11197932

    Polymer-drug conjugates for combination anticancer therapy

    The Regents of the University of California · Granted Dec 14, 2021 · Expires Dec 9, 2041

    granted

  22. US 11197928

    Sustained production of high affinity antigen specific antibody by high dose BAFF receptor-targeting mAb-siRNA conjugate

    The Board of Regents of the University of Texas System · Granted Dec 14, 2021 · Expires Dec 9, 2041

    granted

  23. US 11198685

    Substituted ureas and methods of making and using same

    Mebias Discovery, Inc. · Granted Dec 14, 2021 · Expires Dec 9, 2041

    granted

  24. US 11198876

    Compositions and methods for inhibiting expression of TMPRSS6 gene

    Alnylam Pharmaceuticals, Inc. · Granted Dec 14, 2021 · Expires Dec 9, 2041

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.